JKJonathan Krakoff

Jonathan Krakoff

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jonathan Krakoff has a total of 133 co-authors. Here are the top co-authors by number of shared publications:

  • Paolo Piaggi

    Phoenix Epidemiology and Clinical Research Branch National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes Of Health Phoenix Arizona USA

    14 shared publications
  • Emma J. Stinson

    Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, United States; College of Health Solutions, Arizona State University, Phoenix, AZ, United States

    12 shared publications
  • Robert L. Hanson

    Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Phoenix, AZ 85004

    9 shared publications
  • Susanne B. Votruba

    Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology & Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85004, USA

    8 shared publications
  • Tomás Cabeza de Baca

    Phoenix Epidemiology and Clinical Research Branch National Institute of Diabetes and Digestive and Kidney Diseases Phoenix Arizona USA

    7 shared publications
  • Cassie M. Mitchell

    University of Oklahoma-Health Campus

    5 shared publications

Latest Publications

  • Open Access

    Cholecystectomy Is Linked With Lower Respiratory Exchange Ratio and Higher Lipid Oxidation and Sleep Energy Expenditure

    by Beyza N. Aydin, Emma J. Stinson, Helen C. Looker, Peter Walter, Tomás Cabeza de Baca, Jonathan Krakoff, Douglas C. Chang

    Objective: Cholecystectomy (GBX) may alter energy metabolism, but human evidence is limited. We examined whether GBX alters energy expenditure (EE), respiratory exchange ratio (RER), and substrate oxidation. Methods: A total of 384 healthy Southwestern Indigenous American adults (222 males, age 28 ± 6 years) were studied, including individuals with a history of gallbladder surgery [GBX(+), n = 39] and without surgery [GBX(−), n = 345]. In addition, 24‐h energy metabolism was measured in a respiratory chamber. General linear models were adjusted for age, sex, body composition, and glucose regulation. RER and macronutrient oxidation rates were further adjusted for energy balance. Results: GBX(+) participants were older (31 ± 7 vs. 27 ± 6 years, p = 0.0002) and mostly female (95% vs. 36%, p < 0.0001), and they had higher body fat (40% ± 5% vs. 32% ± 8%, p < 0.0001), although body composition differences were sex related. Adjusted models showed lower RER ( β = −0.01, p = 0.01), higher lipid oxidation ( β = 79 kcal/day, p = 0.03), and higher sleep EE ( β = 78 kcal/day, p = 0.006) in the GBX(+) group. Other EE variables and macronutrient oxidation rates were not significantly associated with GBX history (all p 's > 0.1). Conclusions: Independent of obesity, an absent gallbladder is associated with decreased RER and increased lipid oxidation and sleep EE rates, indicating that the gallbladder may have a role in metabolic fuel selection that has implications for metabolic health. Trial Registration: ClinicalTrials.gov identifiers: NCT00339482, NCT00340132


  • Open Access

    Energy Balance Assessment in a Whole-Room Indirect Calorimeter: Protocol for a Prospective Validation Study (Preprint)

    by Sarah Victoria Frenzel, Kong Y Chen, Paolo Piaggi, Natalia Schischkarjow, Farah Alawa, Lena Sonnefeld, Lars Selig, Jonathan Krakoff, Matthias Blüher, Michael Stumvoll, et al.

  • Open Access

    Association Between Self-Reported Dietary Intake Questionnaires and Objective Measures in an Inpatient Cross-Sectional Study

    by Mary Thompson, Emma J. Stinson, Tomás Cabeza de Baca, Jonathan Krakoff, Susanne Votruba

    Background/Objectives: Measuring dietary intake through self-reported questionnaires can be inaccurate and influenced by sex, eating behavior, and the environment. Here, we compare self-report dietary intake questionnaire responses to objectively measured ad libitum dietary intake in a large, diverse population, and assess differences by sex and food-group composition. Methods: In our inpatient study, from 1999 to 2023, (n = 279) participants completed three different questionnaires assessing different aspects of food intake. Each questionnaire contained the same 77 food items belonging to one of six groups. Groups were either high-fat (HF) or low-fat (LF), then high complex carbohydrate (HCC), high protein (HP), or high simple sugar (HSS). Intake was measured based on the average percent group (PctGrp) intake over three days of ad libitum intake. General linear models, adjusted for relevant covariates and a PctGrp by sex interaction, assessed the relationship between PctGrp intake and questionnaire scores. Results: We found a weak positive correlation between PctGrp intake and food rating (all r ≤ 0.25). There was an interaction between LF/HP and LF/HCC with sex (significant slopes in males only, p = 0.0078, p ≤ 0.0001, respectively). Conclusions: This large study demonstrated little association between self-report dietary questionnaires and intake, especially in females with regards to low-fat foods.

  • Open Access

    Decision-Making Scores and Hunger Susceptibility: A Positive Correlation Mediated by Fasting FGF21 Independently of Body Fat

    by Andrés M. Treviño-Alvarez, Tomás Cabeza de Baca, Emma J. Stinson, Hannah T. Fry, Marci E. Gluck, Douglas C. Chang, Paolo Piaggi, Jonathan Krakoff

    Background/Objectives: Understanding the relationship between metabolism and eating behavior may improve how we treat and prevent obesity. Fibroblast growth factor 21 (FGF21) is a hormone secreted by the liver with a putative role in energy expenditure, energy intake, and weight regulation. In this secondary analysis, we studied how fasting FGF21 is correlated with eating behavior and decision making, as measured by the Three-Factor Eating Questionnaire (TFEQ) and the Iowa Gambling Task (IGT), respectively. Methods: Participants (n = 98; women = 19; white = 31) were medically healthy, between 18 and 55 years of age, weight-stable 6 months before admission, and had normal glucose regulation. Women were premenopausal and not pregnant. Pearson partial correlations were determined, accounting for age, sex, and body fat percentage. A mediation analysis examining whether the association between hunger and IGT score was mediated by FGF21 values was performed using general linear models. Results: In partial correlations adjusted for age, sex, and body fat percentage, we found that fasting FGF21 concentrations were positively correlated with hunger susceptibility (sum of internal and external cues) (partial r = 0.26, p = 0.02) and internal hunger (partial r = 0.22, p = 0.04), disinhibition (partial r = 0.27, p = 0.01), and better decision making (higher IGT scores) (partial r = 0.40, p = 0.0001). We also found a correlation between hunger susceptibility and better decision making, including the same covariates (partial r = 0.25, p = 0.03). However, this correlation was mediated (36%) by fasting FGF21. Conclusions: In this study, participants with greater susceptibility to hunger cues had higher IGT scores (better decision making) in the setting of higher fasting FGF21 concentrations. This provides further evidence of the role of FGF21 in the interplay between eating behavior and decision making. Further studying this topic may improve our understanding of the complex relationship between assessing energy requirements and cognitive processes related to eating behavior.

  • Open Access

    The impact of COVID-19 fear during the later stages of the pandemic on maladaptive eating, psychological distress and body weight: a global cross-sectional study

    by Meeah Willig, Tomás Cabeza de Baca, Emma J. Stinson, Andrés M. Treviño-Alvarez, Theresa Rodzevik, Susanne B. Votruba, Coley C. Lameman, Jonathan Krakoff, Marci E. Gluck

    Background: The COVID-19 pandemic significantly impacted global mental health, leading to increased levels of fear, stress, and anxiety [1]. Previous research has suggested associations between functional fear of detrimental mental health outcomes and psychological stressors which may drive maladaptive eating behaviors. This study explored the associations between COVID-19 fear during later stages of the pandemic, psychological distress (anxiety, depression, and stress), maladaptive eating behaviors (emotional, uncontrolled, binge, and nighttime eating), and self-reported body weight. Methods: This was a global cross-sectional survey conducted from February 2022 to February 2024, involving 4390 adults (70% female) from 25 countries. The survey collected information on demographics, psychosocial impact, eating behaviors, and COVID-19 related behaviors. General linear models, multinomial logistic regression modes, and structural equation modeling were used to analyze the data. Results: Higher fear of COVID-19 was significantly associated with increased emotional and uncontrolled eating, even after adjusting for psychological distress and other covariates. Specifically, each unit increase in fear of COVID-19 scores was associated with a corresponding increase in emotional eating (β = 0.018) and uncontrolled eating (β = 0.029) behaviors (p-values < 0.0001). Furthermore, fear of COVID-19 was linked to higher odds of engaging in binge eating (OR = 1.05, 95% CI: 1.03, 1.07, p-value < 0.0001) and nighttime eating behaviors (OR = 1.04, 95% CI: 1.03, 1.06, p-value < 0.0001) in models adjusted for covariates; however, these associations were no longer significant when psychological distress variables were included. Fear of COVID-19 was also associated with body weight (β = 0.18) and BMI (β = 0.08) even with adjustments of covariates and psychological distress variables (p-values < 0.01). Structural equation modeling showed that fear of COVID-19 was related to current body weight through its impact on psychological distress and maladaptive eating behaviors. Conclusions: Maladaptive eating behaviors influenced by the psychological distress experienced during the COVID-19 pandemic have persisted into the later stages of the pandemic. These results underscore an interconnectedness between functional fear and its influence on maladaptive eating behaviors and body weight. Understanding this link is crucial and has the potential to inform the development of public health policies. Trial registration: Clinical Trials.gov NCT04896060 Date of Registration: May 21, 2021.


  • Open Access

    Human metabolic chambers reveal a coordinated metabolic-physiologic response to nutrition

    by Andrew S. Perry, Paolo Piaggi, Shi Huang, Matthew Nayor, Jane Freedman, Kari E. North, Jennifer E. Below, Clary B. Clish, Venkatesh L. Murthy, Jonathan Krakoff, et al.

    Human studies linking metabolism with organism-wide physiologic function have been challenged by confounding, adherence, and precision. Here, we united physiologic and molecular phenotypes of metabolism during controlled dietary intervention to understand integrated metabolic-physiologic responses to nutrition. In an inpatient study of individuals who underwent serial 24-hour metabolic chamber experiments (indirect calorimetry) and metabolite profiling, we mapped a human metabolome onto substrate oxidation rates and energy expenditure across up to 7 dietary conditions (energy balance, fasting, multiple 200% caloric excess overfeeding of varying fat, protein, and carbohydrate composition). Diets exhibiting greater fat oxidation (e.g., fasting, high-fat) were associated with changes in metabolites within pathways of mitochondrial β-oxidation, ketogenesis, adipose tissue fatty acid liberation, and/or multiple anapleurotic substrates for tricarboxylic acid cycle flux, with inverse associations for diets with greater carbohydrate availability. Changes in each of these metabolite classes were strongly related to 24-hour respiratory quotient (RQ) and substrate oxidation rates (e.g., acylcarnitines related to lower 24-hour RQ and higher 24-hour lipid oxidation), underscoring links between substrate availability, physiology, and metabolism in humans. Physiologic responses to diet determined by gold-standard human metabolic chambers are strongly coordinated with biologically consistent, interconnected metabolic pathways encoded in the metabolome.


  • Hepatic Insulin Resistance Increases Risk of Gallstone Disease in Indigenous Americans in the Southwestern United States

    by Beyza N. Aydin, Emma J. Stinson, Robert L. Hanson, Helen C. Looker, Tomás Cabeza De Baca, Jonathan Krakoff, Douglas C. Chang

    INTRODUCTION: Animal models indicate that hepatic insulin resistance (IR) promotes cholesterol gallstone disease (GSD). We sought to determine whether hepatic and whole-body IR is associated with incident GSD. METHODS: At baseline, 450 Southwestern Indigenous American adults without GSD were included. Participants had a 2-step hyperinsulinemic-euglycemic clamp with glucose tracer at submaximal and maximal insulin stimulation (240 and 2,400 pmol/m2/min) for whole-body IR (M-low and M-high) and hepatic glucose production (HGP) before and during submaximal insulin infusion (HGP-basal and HGP-insulin). Incident GSD was identified during follow-up visits conducted at ∼2-year intervals. The associations of HGP (basal, insulin, and % suppression), M-low, and M-high with risk of GSD were assessed by Cox regression models adjusted for age, sex, body fat (%), glucose, and insulin. RESULTS: Sixty participants (13%) developed GSD (median follow-up: 11.6 years). Participants who developed GSD were of similar age and whole-body IR as those who did not (P's > 0.07) but were more likely to be female; have higher body fat, higher HGP-basal, and HGP-insulin; and lower % suppression of HGP (P's < 0.02). In separate adjusted models, higher HGP-insulin and lower % suppression of HGP were associated with increased risk for GSD (hazard ratio [HR] per SD: HR 1.38, 95% CI 1.12–1.69, P = 0.002; HR 1.41, 95% CI 1.16–1.72, P = 0.0007). HGP-basal, M-low, and M-high were not associated with GSD in adjusted models (P's > 0.22). DISCUSSION: Resistance to insulin suppression of HGP increases risk for GSD. Hepatic IR is a link between GSD and other conditions of the metabolic syndrome.


  • Open Access

    A mixed meal tolerance test predicts onset of type 2 diabetes in Southwestern Indigenous adults

    by Cassie M. Mitchell, Emma J. Stinson, Douglas C. Chang, Jonathan Krakoff

    Background/Objective: To identify predictors of incident type 2 diabetes using a mixed meal tolerance test (MMTT). Methods: Adult Indigenous Americans without diabetes (n = 501) from a longitudinal cohort underwent at baseline a 4-h MMTT, measures of body composition, an oral glucose tolerance test, an intravenous glucose tolerance test for acute insulin response (AIR), and a hyperinsulinemic-euglycemic clamp for insulin action (M). Plasma glucose responses from the MMTT were quantified by the total and incremental area under the curve (AUC/iAUC). Results: At follow-up (median time 9.6 [inter-quartile range: 5.6–13.5] years), 169 participants were diagnosed with diabetes. Unadjusted Cox proportional hazards models, glucose AUC180-min (HR: 1.98, 95% CI: 1.67, 2.34, p < 0.0001), AUC240-min (HR: 1.93, 95% CI: 1.62, 2.31, p < 0.0001), and iAUC180-min (HR: 1.43, 95% CI: 1.20, 1.71, p < 0.0001) were associated with an increased risk of diabetes. After adjustment for covariates (age, sex, body fat percentage, M, AIR, Indigenous American heritage) in three subsequent models, AUC180-min (HR: 1.44, 95% CI: 1.10, 1.88, p = 0.007) and AUC240-min (HR: 1.41, 95% CI: 1.09, 1.84, p < 0.01) remained associated with increased risk of diabetes. Conclusions: Glucose responses to a mixed meal predicted the development of type 2 diabetes. This indicates that a mixed nutritional challenge provides important information on disease risk. Clinical Trial Registry: ClinicalTrials.gov identifier : NCT00340132, NCT00339482


  • Open Access

    Human metabolic chambers reveal a coordinated metabolic-physiologic response to nutrition

    by Andrew S. Perry, Paolo Piaggi, Shi Huang, Matthew Nayor, Jane Freedman, Kari North, Jennifer Below, Clary Clish, Venkatesh L. Murthy, Jonathan Krakoff, et al.

    The emerging field of precision nutrition is based on the notion that inter-individual responses across diets of different calorie-macronutrient content may contribute to inter-individual differences in metabolism, adiposity, and weight gain. Free-living diet studies have been traditionally challenged by difficulties in controlling adherence to prescribed calories and macronutrient content and rarely allow a period of metabolic stability prior to metabolic measures (to minimize influences of weight changes). In this context, key physiologic measures central to precision nutrition responses may be most precisely quantified via whole room indirect calorimetry over 24-h, in which precise control of activity and nutrition can be achieved. In addition, these studies represent unique “N of 1” human crossover metabolic-physiologic experiments during which specific molecular pathways central to nutrient metabolism may be discerned. Here, we quantified 263 circulating metabolites during a ≈40-day inpatient admission in which up to 94 participants underwent seven monitored 24-h nutritional interventions of differing macronutrient composition in a whole-room indirect calorimeter to capture precision metabolic responses. Broadly, we observed heterogenous responses in metabolites across dietary chambers, with the exception of carnitines which tracked with 24-h respiratory quotient. We identified excursions in shared metabolic species (e.g., carnitines, glycerophospholipids, amino acids) that mapped onto gold-standard calorimetric measures of substrate oxidation preference and lipid availability. These findings support a coordinated metabolic-physiologic response to nutrition, highlighting the relevance of these controlled settings to uncover biological pathways of energy utilization during precision nutrition studies.

  • Open Access

    Insulin resistance before type 2 diabetes onset is associated with increased risk of albuminuria after diabetes onset: A prospective cohort study

    by Meeah R. Willig, Emma J. Stinson, Helen C. Looker, Paolo Piaggi, Cassie M. Mitchell, Robert L. Hanson, Robert G. Nelson, Jonathan Krakoff, Douglas C. Chang

    Aim: Reduced renal insulin signalling is implicated in the pathogenesis of albuminuria. We sought to investigate whether insulin action and secretion, measured before diabetes onset, are associated with the development of albuminuria after diabetes onset. Materials and Methods: Baseline body composition, insulin sensitivity by hyperinsulinaemic‐euglycaemic clamp at submaximal and maximal insulin stimulation (240 and 2400 pmol/m 2 /min; M‐low and M‐high), and insulin secretion by intravenous glucose tolerance test [acute insulin response (AIR)] were measured in 170 Southwestern Indigenous American adults who subsequently developed diabetes. After diabetes onset and during the median follow‐up of 13.6 years, 81 participants (48%) developed albuminuria (urine albumin‐to‐creatinine ratio ≥30 mg/g). Separate associations of M‐low, M‐high and AIR (per 1‐SD change) with the risk of albuminuria were assessed by Cox regression models adjusted for age, sex and body fat (%). Results: Participants who developed albuminuria were of similar age (26.4 ± 5.4 vs. 27.5 ± 6.1 years), sex (46% vs. 48% male), body fat (36.4 ± 7.5 vs. 35.7 ± 7.9%) and AIR [2.3 ± 0.3 vs. 2.3 ± 0.3, pmol/L (log)] as those who did not develop albuminuria but had lower insulin sensitivity [M‐low: 0.33 ± 0.08 vs. 0.36 ± 0.12, p = .03; M‐high: 0.87 ± 0.11 vs. 0.91 ± 0.12, p = .02; mg/kg‐metabolic body size/min (log)]. In separate adjusted models, lower M‐low and M‐high were both associated with an increased risk for albuminuria [hazard ratio (HR) 1.51, 95% confidence interval (CI) 1.14, 2.00, p = .004; HR 1.31, 95% CI 1.06, 1.63, p = .01), whereas AIR was not (HR 1.15, 95% CI 0.87, 1.56, p = .3). Conclusions: Lower insulin sensitivity is associated with the development of albuminuria, suggesting a role for insulin signalling in the pathogenesis of proteinuria.